Neal Bhatia, MD discusses the potential role of JAKis in AD, including:

• What changes would JAKis bring to the treatment of AD in the near future?
• What are some JAKis currently under clinical development for AD?
• Do you foresee that JAKis will play a role in both adult and pediatric AD?
• Where do you think they will fit in with the other recently-approved treatments for AD, or overall in the treatment regimen?
• What are the long-term implications for dermatology practice?